Mixed results with endothelin receptor antagonists in cardiovascular disorders

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1307, 2001-01, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential for Endothelin Receptor Antagonists in Cardiovascular Disorders

By Spieker L.E. Noll G. Lüscher T.F.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 4, 2001-04 ,pp. : 293-303

Adis International

Access to resources Recommend Favorite

Endothelin Receptor Antagonists and Cardiovascular Diseases of Aging

By Love M.P.

Drugs & Aging, Vol. 18, Iss. 6, 2001-06 ,pp. : 425-439

Adis International

Access to resources Recommend Favorite

The role of endothelin receptor antagonists in cardiovascular pharmacotherapy

By Münter K. Kirchengast M.

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 1, 2001-04 ,pp. : 3-11

Informa Healthcare

Access to resources Recommend Favorite

Endothelin Receptor Antagonists - An Overview

Current Medicinal Chemistry, Vol. 9, Iss. 5, 2002-03 ,pp. : 549-575

Bentham Science Publishers

Access to resources Recommend Favorite

Mixed results for VEGF gene therapy in cardiovascular disorders

Inpharma, Vol. 1, Iss. 1389, 2003-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite